Anti-PIP5K3 monoclonal antibody

Pre-made anti-PIP5K3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PIP5K3/PIKFYVE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02469-Ab-1/ GM-Tg-hg-T02469-Ab-2Anti-Human PIP5K3/PIKFYVE monoclonal antibodyHuman
GM-Tg-rg-T02469-Ab-1/ GM-Tg-rg-T02469-Ab-2Anti-Rat PIP5K3/PIKFYVE monoclonal antibodyRat
GM-Tg-mg-T02469-Ab-1/ GM-Tg-mg-T02469-Ab-2Anti-Mouse PIP5K3/PIKFYVE monoclonal antibodyMouse
GM-Tg-cynog-T02469-Ab-1/ GM-Tg-cynog-T02469-Ab-2Anti-Cynomolgus/ Rhesus macaque PIP5K3/PIKFYVE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02469-Ab-1/ GM-Tg-felg-T02469-Ab-2Anti-Feline PIP5K3/PIKFYVE monoclonal antibodyFeline
GM-Tg-cang-T02469-Ab-1/ GM-Tg-cang-T02469-Ab-2Anti-Canine PIP5K3/PIKFYVE monoclonal antibodyCanine
GM-Tg-bovg-T02469-Ab-1/ GM-Tg-bovg-T02469-Ab-2Anti-Bovine PIP5K3/PIKFYVE monoclonal antibodyBovine
GM-Tg-equg-T02469-Ab-1/ GM-Tg-equg-T02469-Ab-2Anti-Equine PIP5K3/PIKFYVE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T02469-Ab-1/ GM-Tg-hg-T02469-Ab-2; GM-Tg-rg-T02469-Ab-1/ GM-Tg-rg-T02469-Ab-2;
GM-Tg-mg-T02469-Ab-1/ GM-Tg-mg-T02469-Ab-2; GM-Tg-cynog-T02469-Ab-1/ GM-Tg-cynog-T02469-Ab-2;
GM-Tg-felg-T02469-Ab-1/ GM-Tg-felg-T02469-Ab-2; GM-Tg-cang-T02469-Ab-1/ GM-Tg-cang-T02469-Ab-2;
GM-Tg-bovg-T02469-Ab-1/ GM-Tg-bovg-T02469-Ab-2; GM-Tg-equg-T02469-Ab-1/ GM-Tg-equg-T02469-Ab-2
Products NameAnti-PIP5K3/PIKFYVE monoclonal antibody
Formatmab
Target NamePIP5K3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PIP5K3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T02469-Ag-1Recombinant multi-species FYV1/ PIP5K3/ PIKFYVE protein


    Target information

    Target IDGM-T02469
    Target NamePIP5K3
    Gene ID200576,18711,316457,710115,478890,101094121,790873,100066445
    Gene Symbol and Synonyms5230400C17Rik,CFD,FAB1,fab1-like,HEL37,p235,PIKFYVE,PIP5K,PIP5K3,Pipk5k3,PipkIII,ZFYVE29
    Uniprot AccessionQ9Y2I7
    Uniprot Entry NameFYV1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000115020
    Target ClassificationKinase

    The target: PIP5K3, gene name: PIKFYVE, also named as CFD, FAB1, HEL37, PIP5K, PIP5K3, ZFYVE29. Phosphorylated derivatives of phosphatidylinositol (PtdIns) regulate cytoskeletal functions, membrane trafficking, and receptor signaling by recruiting protein complexes to cell- and endosomal-membranes. Humans have multiple PtdIns proteins that differ by the degree and position of phosphorylation of the inositol ring. This gene encodes an enzyme (PIKfyve; also known as phosphatidylinositol-3-phosphate 5-kinase type III or PIPKIII) that phosphorylates the D-5 position in PtdIns and phosphatidylinositol-3-phosphate (PtdIns3P) to make PtdIns5P and PtdIns(3,5)biphosphate. The D-5 position also can be phosphorylated by type I PtdIns4P-5-kinases (PIP5Ks) that are encoded by distinct genes and preferentially phosphorylate D-4 phosphorylated PtdIns. In contrast, PIKfyve preferentially phosphorylates D-3 phosphorylated PtdIns. In addition to being a lipid kinase, PIKfyve also has protein kinase activity. PIKfyve regulates endomembrane homeostasis and plays a role in the biogenesis of endosome carrier vesicles from early endosomes. The protein plays a key role in cell entry of ebola virus and SARS-CoV-2 by endocytosis Mutations in this gene cause corneal fleck dystrophy (CFD); an autosomal dominant disorder characterized by numerous small white flecks present in all layers of the corneal stroma. Histologically, these flecks appear to be keratocytes distended with lipid and mucopolysaccharide filled intracytoplasmic vacuoles. [provided by RefSeq, Jul 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.